CLINICAL_TRIALS
trial_result
· 2025-02-11
Clinical Trial Update: PRESERVE-MITRAL Post-Market Registry
Summary
A completed post-market registry update for Mitral Valve Disease under Medtronic's PRESERVE-MITRAL program, with results posted on 2025-02-11.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Medtronic Cardiac Surgery | Conditions: Mitral Valve Disease | Status: COMPLETED | Results posted: 2025-02-11